Alan Wookey
Companion Diagnostics, Oncology
Prior to joining Q2 Solutions, Alan Wookey served as Director and Head of the Oncology Biomarker Group at AstraZeneca where he initiated the company’s personalized medicine and pharmacogenetics efforts, as well as their Clinical Biomarkers Group. During his more than 20-year career, Alan also served as Associate Vice President, Global Head of Companion Diagnostics, of LabCorp Clinical Trials (now Covance). 

At Q2 Solutions, he leads business development and scientific strategy for the companion diagnostics and oncology service offerings. He also provides expert consultation in a number of areas including science and technologies, regulatory and management.  Alan earned Bachelor of Science degrees in life sciences and microbiology from the University of Liverpool, and a Post Graduate Diploma in Management Studies from Manchester Metropolitan University.